Everett Harris & CO Biogen Inc. Transaction History

Everett Harris & CO

  • $8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024
BUY
$190.52 - $236.72 $166,323 - $206,656
873 New
873 $202,000
Q3 2022

Oct 21, 2022
BUY
$194.69 - $268.46 $168,017 - $231,680
863 New
863 $230,000
Q1 2022

Apr 22, 2022
SELL
$193.77 - $244.14 $167,223 - $210,692
-863 Closed
0 $0
Q2 2020

Jul 29, 2020
BUY
$258.66 - $342.55 $223,223 - $295,620
863 New
863 $231,000

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Everett Harris & CO Portfolio

Follow Everett Harris & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everett Harris & CO , based on Form 13F filings with the SEC.

News

Stay updated on Everett Harris & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email